Lipoprotein(a) as a determinant of coronary heart disease in young women

Circulation

Volumn 95, Issue 2, 1997, Pages 329-334

  Orth Gomér, Kristina ^a   Mittleman, Murray A ^b   Schenck Gustafsson, Karin ^c   Wamala, Sarah P ^a   Eriksson, Margita ^c   Belkic, Karen ^a   Kirkeeide, Richard ^d   Svane, Bertil ^c   Rydén, Lars ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

coronary disease; lipoproteins; risk factors; women

Indexed keywords

LIPOPROTEIN A;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0031028043     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.2.329     Document Type: Article

References (32)

1. Gurewich V, Mittleman M. Lipoprotein(a) in coronary heart disease: is it a risk factor after all? JAMA. 1994;271:1025-1026.
2. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 1994;271:999-1003.
3. Rosengren A, Wihelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in the general population sample of middle aged men. BMJ. 1990;301:1248-1251.
4. Kark JD, Sandholzer C, Friedlander Y, Utermann G. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case control study in the Jerusalem population. Atherosclerosis. 1993;98:139-151.
5. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol. 1992;69:1251-1254.
6. Bostom AG, Gagnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. Circulation. 1994;90:1688-1695.
7. Ranby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta. 1982;704:461-469.
8. Harpel PC, Gordon BR, Parker TS. Plasmin catalyses binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA. 1989;86:3847-3851.
9. Karadi I, Kostner GM, Gries A, Nimpf J, Romies L, Malle E. Lipoprotein(a) and plasminogen are immunochemichally related. Biochim Biophys Acta. 1988;960:91.
10. Haijar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in artherosclerosis. Nature. 1989;339:303-305.
11. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature. 1989:339:301-303.
12. Reblin T, Meyer N, Labeur C, Henne-Bruns D, Beisiegel U. Extraction of lipoprotein(a), apoB, and apoE from fresh human arterial wall and atherosclerotic plaques. Atherosclerosis. 1995;113:179-188.
13. Myocardial Infarction Community Registers. Results of WHO international collaborative study. WHO Regional Office for Europe, Copenhagen, Sweden; 1976.
14. Gillom RF, Fortman SP, Princas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and stroke. Prog Cardiol. 1984;108:150-157.
15. Braunwald E. Unstable angina: a classification. Circulation. 1989; 80:410-414.
16. Levine DM, Sloan B-J, Donner JE, Lorenz JD, Heinzerling TH. Automated measurement of lipoprotein(a) by immunoturbidimetric analysis. Int J Clin Lab Res. 1992;22:173-178.
17. Riepponen P, Mamiemi J, Rautaoja T. Immunoturbidimetric determination of apolipoprotein A-l and B in serum. Scand J Clin Lab Invest. 1987:47:739.
18. Jungner I, Walldius G, Holme I, Steiner E. Apolipoprotein B and A-l in relation to serum cholesterol and triglycerides in 43000 Swedish males and females. Int J Clin Lab Res. 1992;21:247-255.
19. Rothman KJ. Modem Epidemiology. Boston, Mass: Little, Brown & Co; 1986.
20. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 1991;89:59-67.
21. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 1993; 270:2195-2199.
22. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo Study. Atherosclerosis. 1993;99:87-95.
23. Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
24. Solymon BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein(a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol. 1993; 72:1215-1219.
25. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyidermans L, Vanderkerhove Y, Van der Stichele E, Rousseneu M. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem. 1992;38:2261-2266.
26. Terres W, Tatsis E, Pfalzer B, Beil U, Beisiegel U, Hamm ChW. Rapid angiographie progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 1995:91:948-950.
27. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995;91: 1403-1409.
28. Slunga L, Johnson O, Dahlén GH, Eriksson S. Lipoprotein(a) and acute-phase proteins in acute myocardial infarction. Scand J Clin Lab Invest. 1992:52:95-101.
29. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 1989:78:145-150.
30. American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement. Dallas, Tex: American Heart Association; 1994.
31. Craig WY, Ledue TB. The effects of long term storage on serum Lp(a) levels. Atherosclerosis. 1992:93:261.
32. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex and menopausal status on Lp(a) levels: Framingham Off-spring Study. Circulation. 1993; 87:1135-1141.